{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-071347","form_type":"8-K","ticker":"CVSI","cik":"0001510964","company_name":"CV Sciences, Inc.","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.545705+00:00","generated_at":"2026-05-21T08:30:16.456696+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"CV Sciences Q1 2025 revenue $3.6M (-10% YoY); turns operating profit $11K","bullets":["Q1 revenue $3.6M vs $4.0M YoY; unit volume down 11.8%, partially offset by 0.9% price increase.","Operating income of $11K vs $0.6M loss YoY, boosted by $0.5M reversal of accrued payroll taxes.","Adjusted EBITDA loss improved to $0.3M from $0.5M YoY; gross margin 46.0% vs 46.3%.","Launched Lunar Fox plant-based product line with 7 vegan products in U.S. retail and online.","Raised $1.2M net from institutional investor in Q1; cash balance $0.8M vs $0.5M end-2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-071347","json":"https://secwatch.observer/filing/0000950170-25-071347.json","markdown":"https://secwatch.observer/filing/0000950170-25-071347.md","text":"https://secwatch.observer/filing/0000950170-25-071347.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1510964/000095017025071347/0000950170-25-071347-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1510964/000095017025071347/cvsi-20250514.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T08:30:16.456696+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}